Sponsor Dossier
ViiV Healthcare
Sponsor Dossier for ViiV Healthcare. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: 3TC
- Brand: APRETUDE
- Brand: CABENUVA
- Brand: CELSENTRI
- Brand: COMBIVIR
- Brand: DOVATO
- Brand: JULUCA
- Brand: KIVEXA
About
ViiV Healthcare is an Australian Private Company with ABN 46 138 687 448, registered in Victoria. The entity is active and registered for GST.
Portfolio
ViiV Healthcare maintains 14 brands on the ARTG, all of which are indexable. All 14 brands have Product Information on file. Five brands have at least one PBS-listed item, seven brands have PBAC outcomes on record, and eight brands have AusPARs on record. Notable brands in the portfolio include 3TC, APRETUDE, CABENUVA, CELSENTRI, COMBIVIR, DOVATO, JULUCA, KIVEXA, RETROVIR, RUKOBIA, TIVICAY, and TRIUMEQ.
Therapeutic focus
— Infectious Disease: 14 brands
PBS footprint
Five brands in the ViiV Healthcare portfolio are PBS-listed, with the latest schedule date update occurring on 1 May 2026.
Regulatory activity
The most recent PBAC outcome for ViiV Healthcare is dated 1 September 2023, with seven brands holding PBAC outcomes on record. The most recent AusPAR is dated 8 August 2022, with eight brands holding AusPARs on record.